Publishing research using ab5650? Please let us know so that we can cite the reference in this datasheet.

ab5650 has been referenced in 6 publications.

  • Xu X  et al. MUC1 contributes to BPDE-induced human bronchial epithelial cell transformation through facilitating EGFR activation. PLoS One 7:e33846 (2012). WB ; Human . PubMed: 22457794
  • Li Z  et al. Epidermal Growth Factor Receptor-mediated Tissue Transglutaminase Overexpression Couples Acquired Tumor Necrosis Factor-related Apoptosis-inducing Ligand Resistance and Migration through c-FLIP and MMP-9 Proteins in Lung Cancer Cells. J Biol Chem 286:21164-72 (2011). WB ; Human . PubMed: 21525012
  • Pedersen NM  et al. Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2. Mol Cancer Res 7:275-84 (2009). WB . PubMed: 19208749
  • Juarez JC  et al. Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling. Proc Natl Acad Sci U S A 105:7147-52 (2008). WB ; Human . PubMed: 18480265
  • Moore T  et al. Reduced susceptibility to two-stage skin carcinogenesis in mice with low circulating insulin-like growth factor I levels. Cancer Res 68:3680-8 (2008). WB ; Mouse . PubMed: 18483250
  • Lu J  et al. Activation of epidermal akt by diverse mouse skin tumor promoters. Mol Cancer Res 5:1342-52 (2007). PubMed: 18171992

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"